F Sheftell
Overview
Explore the profile of F Sheftell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bayliss M, Dewey J, Dunlap I, Batenhorst A, Cady R, Diamond M, et al.
Qual Life Res
. 2003 Dec;
12(8):953-61.
PMID: 14651414
Background: Headache impact test (HIT) is a precise, practical tool that quantifies the impact of headache on respondents' lives. It is the first widely-available dynamic health assessment (DynHA). Applications of...
2.
Tepper S, Rapoport A, Sheftell F
Neurologist
. 2003 Jun;
7(5):279-86.
PMID: 12803669
Background: Migraine results from episodic changes in central nervous system physiologic function in hyperexcitable brain manifested by abnormal energy metabolism, lowered threshold for phosphene generation, and increased contingent negative variation....
3.
Sheftell F, Dodick D, Cady R
Headache
. 2001 Jul;
41(6):534-6.
PMID: 11437886
No abstract available.
4.
Cady R, Sheftell F, Lipton R, Kwong W, OQuinn S
Clin Ther
. 2001 Apr;
23(2):284-91.
PMID: 11293561
Background: Early treatment of migraine with sumatriptan 50 mg and 100 mg, while pain is mild, has been reported to enhance pain-free response 2 hours and 4 hours postdose and...
5.
Cady R, Sheftell F, Lipton R, OQuinn S, Jones M, Putnam D, et al.
Clin Ther
. 2000 Oct;
22(9):1035-48.
PMID: 11048903
Objective: This study assessed the efficacy of sumatriptan 50- and 100-mg tablets in the treatment of migraine attacks while the pain is mild rather than moderate/severe. Background: Results from The...
6.
Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S
Headache
. 2000 Apr;
40(2):158-63.
PMID: 10759916
Objective: Clinical observation of a decrease in migraine frequency in patients with comorbid asthma taking montelukast, a specific D4 leukotriene receptor antagonist, or zafirlukast, another leukotriene receptor antagonist, prompted us...
7.
Sheftell F, OQuinn S, Watson C, Pait D, Winter P
Headache
. 2000 Apr;
40(2):103-10.
PMID: 10759909
Objective: To evaluate clinical parameters that may affect the incidence of headache recurrence or the time to headache recurrence, or both, in migraineurs treated with naratriptan, 2.5-mg tablets. Background: The...
8.
Lipton R, Stewart W, Ryan Jr R, Saper J, Silberstein S, Sheftell F
Arch Neurol
. 1998 Mar;
55(2):210-7.
PMID: 9482363
Objective: To assess the effectiveness of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain. Design: Three double-blind, randomized, parallel-group, single-dose, placebo-controlled studies. Setting: Private practice,...
9.
Lipton R, RASKIN N, Ruoff G, Saper J, Sheftell F, Solomon S
Am J Kidney Dis
. 1996 Jun;
27(6):917-8.
PMID: 8651260
No abstract available.
10.
Winner P, DAlessio D, Mathew N, Sadowsky C, Turkewitz L, Sheftell F, et al.
Am J Emerg Med
. 1994 Mar;
12(2):138-41.
PMID: 8161382
The influence of concomitant administration of an antiemetic agent on the course of nausea was assessed in a field trial of intramuscular dihydroergotamine for the treatment of acute migraine. Of...